1. India Stocks

  2. •

    Healthcare

  3. •

    Medical - Distribution
Everest Organics Limited

Everest Organics Limited

EVERESTO.BO
Everest Organics LimitedIN flagBombay Stock Exchange
273.70
INR
+6.50
- -
2.66BMarket Cap

Total Valuation

Everest Organics Limited carries a market capitalization of 2.66B, placing it among publicly traded companies globally. Its enterprise value stands at 2.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.66B
Enterprise Value2.46B

Share Statistics

Everest Organics Limited currently has 9.71M shares outstanding.

Shares Outstanding9.71M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Everest Organics Limited trades at a trailing price-to-earnings ratio of 35.59. The price-to-sales ratio is 1.01, and the price-to-book ratio stands at 20.33.

PE Ratio35.59
PS Ratio1.01
PB Ratio20.33
P/TBV Ratio2.75
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Everest Organics Limited trades at an EV/EBITDA multiple of 18.49 and an EV/FCF ratio of 54.76. The EV/Sales ratio of 1.26 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 18.49 provides insight into valuation relative to core operating earnings.

EV / Sales1.26
EV / EBITDA18.49
EV / EBIT18.49
EV / FCF54.76

Financial Position

Everest Organics Limited maintains a current ratio of 1.10, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 66.16, indicating elevated leverage, while an interest coverage ratio of 2.04 demonstrates limited ability to service its debt obligations.

Current Ratio1.10
Quick Ratio0.01
Debt / Equity66.16
Debt / EBITDA3.75
Interest Coverage2.04

Financial Efficiency

Everest Organics Limited posts a return on equity of 21.91 and a return on invested capital of 7.62.

Return on Equity (ROE)21.91
Return on Assets (ROA)2.39
Return on Invested Capital (ROIC)7.62
Return on Capital Employed (ROCE)13.53
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.74

Taxes

Over the trailing twelve months, Everest Organics Limited has paid 25.00M in income taxes, reflecting an effective tax rate of 31.07.

Income Tax25.00M
Effective Tax Rate31.07

Stock Price Statistics

Everest Organics Limited's stock has declined approximately -19.5% over the past 52 weeks. The 50-day moving average sits at 259.58, while the 200-day moving average is 352.31.

Beta (5Y)N/A
52-Week Price Change-19.5%
50-Day Moving Average259.58
200-Day Moving Average352.31
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Everest Organics Limited generated 1.96B in revenue and converted that into 55.47M in net income, yielding earnings per share of 5.72. EBITDA reached 133.28M, while operating income came in at 133.28M.

Revenue1.96B
Gross Profit728.00M
Operating Income133.28M
Pretax Income80.47M
Net Income55.47M
EBITDA133.28M
EBIT133.28M
Earnings Per Share (EPS)5.72

Balance Sheet

Everest Organics Limited holds 9.53M in cash and equivalents against 499.34M in total debt, resulting in a net debt position of 498.32M. Total book value stands at 97.11M, with working capital of 152.32M providing operational flexibility.

Cash & Cash Equivalents9.53M
Total Debt499.34M
Net Debt498.32M
Equity (Book Value)97.11M
Book Value Per Share10.01
Working Capital152.32M

Margins

Everest Organics Limited operates with a gross margin of 37.11, reflecting its pricing power and cost economics. The operating margin of 6.79 and net profit margin of 2.83 provide insight into operational efficiency.

Gross Margin37.11
Operating Margin6.79
Pretax Margin4.10
Profit Margin2.83
EBITDA Margin6.79

Scores

Everest Organics Limited posts an Altman Z-Score of 1.82, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.82